Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery

NCT00847301 · clinicaltrials.gov ↗
COMPLETED
Status
472
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Boehringer Ingelheim